1. Home
  2. COLD vs RCUS Comparison

COLD vs RCUS Comparison

Compare COLD & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Americold Realty Trust Inc.

COLD

Americold Realty Trust Inc.

HOLD

Current Price

$12.84

Market Cap

3.1B

Sector

Real Estate

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$21.47

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COLD
RCUS
Founded
1903
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.1B
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
COLD
RCUS
Price
$12.84
$21.47
Analyst Decision
Buy
Buy
Analyst Count
14
8
Target Price
$15.93
$29.38
AVG Volume (30 Days)
7.6M
2.1M
Earning Date
11-06-2025
10-28-2025
Dividend Yield
7.23%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,607,407,000.00
$240,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.10
$6.50
52 Week High
$23.52
$26.40

Technical Indicators

Market Signals
Indicator
COLD
RCUS
Relative Strength Index (RSI) 67.28 42.60
Support Level $10.51 $20.35
Resistance Level $11.33 $26.10
Average True Range (ATR) 0.45 1.48
MACD 0.32 -0.59
Stochastic Oscillator 96.90 18.43

Price Performance

Historical Comparison
COLD
RCUS

About COLD Americold Realty Trust Inc.

Americold Realty Trust Inc is the world's second-largest owner and operator of temperature-controlled warehouses behind privately held Lineage Logistics. The Atlanta, Georgia-based firm owns and operates approximately 239 temperature-controlled warehouses, spanning 1.4 billion cubic feet. In 2022, the firm derived more than 80% of its revenue from the United States but also has sizable operations in Europe, Canada, Australia, and New Zealand. Americold supplements its core business by providing supply management and transportation services to its various customers. It operates as a real estate investment trust.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: